These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30165501)

  • 21. General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.
    Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
    Int J Clin Pract; 2016 Mar; 70(3):261-76. PubMed ID: 26918508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [MEDICATIONS DEPRESCRIBING IN ELDERLY NURSING HOME RESIDENTS].
    Aizen E; Hindawil E; Hijazi M; Merih A; Shahla H; Elyounes AA
    Harefuah; 2016 Mar; 155(3):145-9, 197. PubMed ID: 27305746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study.
    AlRasheed MM; Alhawassi TM; Alanazi A; Aloudah N; Khurshid F; Alsultan M
    Clin Interv Aging; 2018; 13():1401-1408. PubMed ID: 30122912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing inappropriate polypharmacy: the process of deprescribing.
    Scott IA; Hilmer SN; Reeve E; Potter K; Le Couteur D; Rigby D; Gnjidic D; Del Mar CB; Roughead EE; Page A; Jansen J; Martin JH
    JAMA Intern Med; 2015 May; 175(5):827-34. PubMed ID: 25798731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferences for deprescribing antihypertensive medications amongst clinicians, carers and people living with dementia: a discrete choice experiment.
    Raghunandan R; Howard K; Ilomaki J; Hilmer SN; Gnjidic D; Bell JS
    Age Ageing; 2023 Aug; 52(8):. PubMed ID: 37596920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing deprescribing habits among geriatricians.
    Ní Chróinín D; Ní Chróinín C; Beveridge A
    Age Ageing; 2015 Jul; 44(4):704-8. PubMed ID: 25758409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deprescribing in Advanced Illness: Aligning Patient, Clinician, and Health Plan Goals.
    Parekh N; Schenker Y; Good CB; Neilson L; Shrank WH
    J Gen Intern Med; 2019 Apr; 34(4):631-633. PubMed ID: 30719644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New horizons in deprescribing for older people.
    Woodford HJ; Fisher J
    Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-design of a behaviour change intervention to equip geriatricians and pharmacists to proactively deprescribe medicines that are no longer needed or are risky to continue in hospital.
    Scott S; Atkins B; Kellar I; Taylor J; Keevil V; Alldred DP; Murphy K; Patel M; Witham MD; Wright D; Bhattacharya D
    Res Social Adm Pharm; 2023 May; 19(5):707-716. PubMed ID: 36841632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
    Palagyi A; Keay L; Harper J; Potter J; Lindley RI
    BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collaborative Deprescribing in Borderline Personality Disorder: A Narrative Review.
    Fineberg SK; Gupta S; Leavitt J
    Harv Rev Psychiatry; 2019; 27(2):75-86. PubMed ID: 30676404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deprescribing recommendations: An essential consideration for clinical guideline developers.
    Moriarty F; Pottie K; Dolovich L; McCarthy L; Rojas-Fernandez C; Farrell B
    Res Social Adm Pharm; 2019 Jun; 15(6):806-810. PubMed ID: 30241877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescribing and deprescribing antihypertensive medication in older people by Dutch general practitioners: a qualitative study.
    van Middelaar T; Ivens SD; van Peet PG; Poortvliet RKE; Richard E; Pols AJ; Moll van Charante EP
    BMJ Open; 2018 Apr; 8(4):e020871. PubMed ID: 29678989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.
    Reeve E; Thompson W; Farrell B
    Eur J Intern Med; 2017 Mar; 38():3-11. PubMed ID: 28063660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. We have had a gutful: The need for deprescribing proton pump inhibitors.
    Naunton M; Peterson GM; Deeks LS; Young H; Kosari S
    J Clin Pharm Ther; 2018 Feb; 43(1):65-72. PubMed ID: 28895169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementing deprescribing guidelines into frontline practice: Barriers and facilitators.
    Conklin J; Farrell B; Suleman S
    Res Social Adm Pharm; 2019 Jun; 15(6):796-800. PubMed ID: 30241874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Older Adults' Awareness of Deprescribing: A Population-Based Survey.
    Turner JP; Tannenbaum C
    J Am Geriatr Soc; 2017 Dec; 65(12):2691-2696. PubMed ID: 28913911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: A systematic review.
    Lundby C; Graabaek T; Ryg J; Søndergaard J; Pottegård A; Nielsen DS
    Br J Clin Pharmacol; 2019 May; 85(5):868-892. PubMed ID: 30630219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners.
    Luymes CH; van der Kleij RM; Poortvliet RK; de Ruijter W; Reis R; Numans ME
    Ann Pharmacother; 2016 Jun; 50(6):446-54. PubMed ID: 26939589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.